Humana (HUM) Receives a Buy from Wells Fargo
Wells Fargo analyst Steve Baxter maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $315.00. The ...
Humana price target raised to $315 from $290 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on Humana (HUM) to $315 from $290 and keeps an Overweight rating on the ...
Analysts Set Humana Inc. (NYSE:HUM) PT at $315.86
Shares of Humana Inc. (NYSE:HUM – Get Free Report) have received a consensus recommendation of “Hold” from the twenty-five ...
Several Headwinds Dragged Humana (HUM) in Q3
Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A ...
Sigma Planning Corp Sells 1,255 Shares of Humana Inc. (NYSE:HUM)
Sigma Planning Corp cut its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 65.7% during the third quarter, ...
Do You Believe in Humana Inc. (HUM)’s Long-Term Strength?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2024 investor letter. A ...
Here’s What Weighed On The Results of Lancaster Colony Corporation (LANC)
Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A ...
Clover Health: Buy The Dip, Reap The Rewards
Clover Health’s 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why I’m reiterating ...
bovnews3d
Humana Inc (HUM) Stock: More Robust Than the Numbers Suggest?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.25% of ...
Yahoo Finance4d
The Cigna Group (CI)
Firstly, we'll want to... Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints Cigna's bold move to halt merger ...